ECSP066649A - Preparado efervescente de una sustancia básica farmacéuticamente activa - Google Patents

Preparado efervescente de una sustancia básica farmacéuticamente activa

Info

Publication number
ECSP066649A
ECSP066649A EC2006006649A ECSP066649A ECSP066649A EC SP066649 A ECSP066649 A EC SP066649A EC 2006006649 A EC2006006649 A EC 2006006649A EC SP066649 A ECSP066649 A EC SP066649A EC SP066649 A ECSP066649 A EC SP066649A
Authority
EC
Ecuador
Prior art keywords
pharmaceutically active
basic substance
effective preparation
active basic
preparation
Prior art date
Application number
EC2006006649A
Other languages
English (en)
Spanish (es)
Inventor
Wolfgang Wiehl
Irene Loose
Ralf Buellesbach
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of ECSP066649A publication Critical patent/ECSP066649A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
EC2006006649A 2003-12-19 2006-06-16 Preparado efervescente de una sustancia básica farmacéuticamente activa ECSP066649A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10359790A DE10359790A1 (de) 2003-12-19 2003-12-19 Brausezubereitung einer basischen arzneilich wirksamen Substanz

Publications (1)

Publication Number Publication Date
ECSP066649A true ECSP066649A (es) 2006-10-25

Family

ID=34683574

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006649A ECSP066649A (es) 2003-12-19 2006-06-16 Preparado efervescente de una sustancia básica farmacéuticamente activa

Country Status (16)

Country Link
EP (1) EP1696874A1 (no)
JP (1) JP2007515418A (no)
KR (1) KR20060109492A (no)
CN (1) CN1893920A (no)
AR (1) AR046955A1 (no)
AU (1) AU2004308590A1 (no)
BR (1) BRPI0417796A (no)
CA (1) CA2550342A1 (no)
DE (1) DE10359790A1 (no)
EC (1) ECSP066649A (no)
IL (1) IL176356A0 (no)
MA (1) MA28276A1 (no)
MX (1) MXPA06006658A (no)
NO (1) NO20063327L (no)
WO (1) WO2005063199A1 (no)
ZA (1) ZA200604946B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
TR201107202T1 (tr) * 2008-11-11 2012-02-21 Berko İlaç Ve Ki̇mya Sanayi̇ A.Ş. İbuprofen, psödoefedrin ve klorfeniramin içeren bir farmasötik bileşim.
RU2547562C2 (ru) * 2009-05-27 2015-04-10 Дасан Медикем Ко., Лтд. Многослойная таблетка, содержащая эффервесцентный слой
WO2013109224A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical compositions comprising diclofenac
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
CN107951034B (zh) * 2017-12-01 2021-03-23 郑州拓洋生物工程有限公司 维生素泡腾制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
CA2084028A1 (en) * 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
AU7407194A (en) * 1993-08-03 1995-02-28 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
JP2000063269A (ja) * 1998-08-20 2000-02-29 Taiho Yakuhin Kogyo Kk 固形製剤

Also Published As

Publication number Publication date
CN1893920A (zh) 2007-01-10
AR046955A1 (es) 2006-01-04
NO20063327L (no) 2006-07-18
AU2004308590A1 (en) 2005-07-14
IL176356A0 (en) 2006-10-05
ZA200604946B (en) 2007-09-26
KR20060109492A (ko) 2006-10-20
CA2550342A1 (en) 2005-07-14
MXPA06006658A (es) 2006-08-31
BRPI0417796A (pt) 2007-03-20
DE10359790A1 (de) 2005-07-21
WO2005063199A1 (de) 2005-07-14
EP1696874A1 (de) 2006-09-06
JP2007515418A (ja) 2007-06-14
MA28276A1 (fr) 2006-11-01

Similar Documents

Publication Publication Date Title
ES2557988T3 (es) Método para tratar enfermedades de próstata basado en el suministro local de principios activos
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
CL2007000601A1 (es) Compuestos derivados de heterobiciclos pirazolicos, inhibidores de la actividad de proteina tiroxina quinasa; composicion farmaceutica que comprende dichos compuestos; y uso de los compuestos en el tratamiento de una enfermedad hiperproliferativa.
EA200501586A1 (ru) Фармацевтические продукты
UY27940A1 (es) Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a
CU23367A3 (es) Formulación de moxifloxacino con sal común
CL2007003520A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer.
BRPI0410503B8 (pt) composição tópica e uso da composição
TW200640487A (en) Combination of XOLAIR with immunosuppressive agent
ECSP088962A (es) Nuevos herbicidas
CL2007001427A1 (es) Sal de maleato de 5-amino-3-(2',3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d]pirimidin-2-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una infeccion po
ECSP066649A (es) Preparado efervescente de una sustancia básica farmacéuticamente activa
BRPI0718523B8 (pt) Forma de dosagem, e, método para preparar a forma de dosagem
DE60105448D1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
AR058173A1 (es) Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
CL2004001012A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
MA30815B1 (fr) Medicament combine
AR046402A1 (es) Combinacion de principio activo que comprende un compuesto 2,5-dihidrobencenosulfonico y un modulador de los canales de potasio
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
AR043327A1 (es) Uso de inhibidores de quinurenina 3- hidroxilasa para el tratamiento de la diabetes
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
HUP0204208A2 (hu) Pruritus kezelésére szolgáló külsőleges gyógyszerkészítmény
CU20060130A7 (es) Preparado efervescente de una sustancia básica farmacéuticamente activa